Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium–Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes

OBJECTIVE: To determine the respective associations of premorbid glucagon-like peptide-1 receptor agonist (GLP1-RA) and sodium–glucose cotransporter 2 inhibitor (SGLT2i) use, compared with premorbid dipeptidyl peptidase 4 inhibitor (DPP4i) use, with severity of outcomes in the setting of severe acut...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Care
Autors principals: Kahkoska, Anna R., Abrahamsen, Trine Julie, Alexander, G. Caleb, Bennett, Tellen D., Chute, Christopher G., Haendel, Melissa A., Klein, Klara R., Mehta, Hemalkumar, Miller, Joshua D., Moffitt, Richard A., Stürmer, Til, Kvist, Kajsa, Buse, John B.
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2021
Matèries:
Epidemiology/Health Services Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8323175/
https://ncbi.nlm.nih.gov/pubmed/34135013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc21-0065
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars